Nicole Nath | Manager, Investor Relations |
Michael Minogue | President and Chief Executive Officer |
Todd Trapp | Vice President and Chief Financial Officer |
Matthew O’Brien | Piper Sandler |
Marie Thibault | BTIG |
Brandon Vazquez | William Blair & Company |
Danielle Antalffy | SVB Leerink |
Imron Zafar | Deutsche Bank |
Michael Polark | Wolfe Research |
Christopher Cooley | Stephens Inc |
Hello, and a warm welcome to today’s Abiomed Fiscal Year 2022 Fourth Quarter Earnings Call. My name is Emma, and I will be coordinating the call today. [Operator Instructions] It is now my pleasure to hand today’s call over to Nicole Nath, Head of Investor Relations to begin. Over to you Nicole.
Good morning and welcome to Abiomed’s fourth quarter fiscal 2022 earnings conference call.